Ultrasound-guided Thermal Ablation for Bethesda III/IV Thyroid Nodules
Recruiting now
Conditions studied: Thyroid Nodule
In brief
To evaluate the long-term outcomes of ultrasound-guided thermal ablation for Bethesda III/IV thyroid nodules
Key facts
- Study ID
- NCT06733753
- Run by
- Chinese PLA General Hospital
- People needed
- 600
- Starts
- 2024-12-09
- Expected to finish
- 2030-12-31
- Last updated by the study team
- 2025-02-14
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- confirmation of Bethesda III or IV on fine- needle aspiration and negative on Braf V600E test
- no clinical or imaging evidences of extrathyroidal extension, lymph node metastasis and distant metastasis on ultrasound, neck and chest CT
- refusal or ineligibility for surgery
- follow-up time ≥12 months
You may not qualify if…
- follicular neoplasm or malignancy findings on biopsy
- no suspicious of malignancy in US
- patients with contra-lateral vocal cord paralysis
- follow- up time less than 12 months
Where it is running
- Chinese PLA General Hospital — Beijing, Beijing Municipality, China (enrolling)
- Chinese PLA General Hospital — Beijing, China
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.